Clinical Trial Update: Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning [Phase 1]

View source ↗

Summary

An early-stage trial evaluating anti-PSMA designer T cells for advanced prostate cancer has been suspended after non-myeloablative conditioning.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Anti-PSMA Designer T Cells (PSMA-targeted T cells (designer))

Snippet

Sponsor: Roger Williams Medical Center | Conditions: Prostate Cancer | Phase 1 | Status: SUSPENDED